BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 37147944)

  • 1. Measurement of dose enhancement factor for Xoft Axxent electronic brachytherapy device using nanoparticle-embedded alginate film and radiochromic film.
    Kakade NR; Das A; Kumar R; Sharma SD; Maiti N; Chadha R; Sapra BK
    J Cancer Res Ther; 2023 Apr; 19(Supplement):S0. PubMed ID: 37147944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of unlaminated EBT3 film dosimeter for quantification of dose enhancement using silver nanoparticle-embedded alginate film.
    Kakade NR; Das A; Kumar R; Sharma SD; Chadha R; Maiti N; Kapoor S
    Biomed Phys Eng Express; 2022 Apr; 8(3):. PubMed ID: 35325874
    [No Abstract]   [Full Text] [Related]  

  • 3. Determination of dose enhancement caused by AuNPs with Xoft
    Shahhoseini E; Ramachandran P; Patterson WR; Geso M
    Int J Nanomedicine; 2018; 13():5733-5741. PubMed ID: 30310276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Xoft Axxent electronic brachytherapy: a new device for delivering brachytherapy to the breast.
    Dickler A
    Nat Clin Pract Oncol; 2009 Mar; 6(3):138-42. PubMed ID: 19174776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of a source model for a new electronic brachytherapy tandem by film measurement.
    Martin E; Sowards K; Wang B
    J Appl Clin Med Phys; 2018 Sep; 19(5):640-650. PubMed ID: 30105891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurement of gold nanofilm dose enhancement using unlaminated radiochromic film.
    Rakowski JT; Laha SS; Snyder MG; Buczek MG; Tucker MA; Liu F; Mao G; Hillman Y; Lawes G
    Med Phys; 2015 Oct; 42(10):5937-44. PubMed ID: 26429268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted radiotherapy enhancement during electronic brachytherapy of accelerated partial breast irradiation (APBI) using controlled release of gold nanoparticles.
    Cifter G; Chin J; Cifter F; Altundal Y; Sinha N; Sajo E; Ngwa W
    Phys Med; 2015 Dec; 31(8):1070-1074. PubMed ID: 26404139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accelerated brachytherapy with the Xoft electronic source used in association with iodine, gold, bismuth, gadolinium, and hafnium nano-radioenhancers.
    Mesbahi A; Rajabpour S; Smilowitz HM; Hainfeld JF
    Brachytherapy; 2022; 21(6):968-978. PubMed ID: 36002350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calculated and measured radiation dose for the low energy xoft axxent eBT X-ray source.
    Can S; Atilla Ö; Karaçetin D
    BMC Res Notes; 2023 Feb; 16(1):25. PubMed ID: 36855193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling study for optimization of skin dose for partial breast irradiation using Xoft Axxent electronic brachytherapy applicator.
    Hepel JT; Hiatt JR; Cardarelli GA; Wazer DE
    Brachytherapy; 2010; 9(1):81-5. PubMed ID: 19850533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose measurements nearby low energy electronic brachytherapy sources using radiochromic film.
    Devic S; Liang L; Tomic N; Bekerat H; Morcos M; Popovic M; Watson P; Aldelaijan S; Seuntjens J
    Phys Med; 2019 Aug; 64():40-44. PubMed ID: 31515034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Axxent-Xoft, (192)Ir and (60)Co high-dose-rate brachytherapy sources for image-guided brachytherapy treatment planning for cervical cancer.
    Mobit PN; Packianathan S; He R; Yang CC
    Br J Radiol; 2015 Aug; 88(1052):20150010. PubMed ID: 25996576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. I-125 ROPES eye plaque dosimetry: validation of a commercial 3D ophthalmic brachytherapy treatment planning system and independent dose calculation software with GafChromic® EBT3 films.
    Poder J; Corde S
    Med Phys; 2013 Dec; 40(12):121709. PubMed ID: 24320495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A dosimetric comparison of MammoSite high-dose-rate brachytherapy and Xoft Axxent electronic brachytherapy.
    Dickler A; Kirk MC; Seif N; Griem K; Dowlatshahi K; Francescatti D; Abrams RA
    Brachytherapy; 2007; 6(2):164-8. PubMed ID: 17434111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement of the modified TG43 parameters for the bare S7600 Xoft Axxent source model.
    Walter AE; Khan AU; DeWerd LA
    Brachytherapy; 2023; 22(2):260-268. PubMed ID: 36623989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Photon energy dependence of the sensitivity of radiochromic film and comparison with silver halide film and LiF TLDs used for brachytherapy dosimetry.
    Muench PJ; Meigooni AS; Nath R; McLaughlin WL
    Med Phys; 1991; 18(4):769-75. PubMed ID: 1921886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Xoft Axxent electronic brachytherapy.
    Dickler A; Dowlatshahi K
    Expert Rev Med Devices; 2009 Jan; 6(1):27-31. PubMed ID: 19105777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and dosimetric characteristics of a new endocavitary contact radiotherapy system using an electronic brachytherapy source.
    Richardson S; Garcia-Ramirez J; Lu W; Myerson RJ; Parikh P
    Med Phys; 2012 Nov; 39(11):6838-46. PubMed ID: 23127076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A detailed Monte Carlo evaluation of
    Gray T; Bassiri N; David S; Patel DY; Stathakis S; Kirby N; Mayer KM
    Phys Med Biol; 2020 Jul; 65(13):135007. PubMed ID: 32434159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Gold Nanoparticle Radiosensitization on Plasmid DNA Damage Induced by High-Dose-Rate Brachytherapy.
    Yogo K; Misawa M; Shimizu M; Shimizu H; Kitagawa T; Hirayama R; Ishiyama H; Furukawa T; Yasuda H
    Int J Nanomedicine; 2021; 16():359-370. PubMed ID: 33469290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.